�ݺ�ߣshows by User: SawsanMonir

�ݺ�ߣshows by User: SawsanMonir / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: SawsanMonir / Sat, 11 May 2019 06:48:48 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: SawsanMonir Dendrimers for Target Drug Delivery In Treatment of Cancer /slideshow/dendrimers-for-target-drug-delivery-in-treatment-of-cancer/144934614 reviewarticle-190511064848
Dendrimers are emerging as potential non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. These polymers are highly branched, three-dimensional macromolecules with modifiable surface functionalities and available internal cavities that make them attractive as delivery systems for drug and gene delivery applications. Recent work has suggested that dendrimers may be a keystone in the future of therapeutics, Dendrimers can also be being applied to a variety of cancer therapies to improve their safety and efficacy.]]>
Dendrimers are emerging as potential non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. These polymers are highly branched, three-dimensional macromolecules with modifiable surface functionalities and available internal cavities that make them attractive as delivery systems for drug and gene delivery applications. Recent work has suggested that dendrimers may be a keystone in the future of therapeutics, Dendrimers can also be being applied to a variety of cancer therapies to improve their safety and efficacy.]]> Sat, 11 May 2019 06:48:48 GMT /slideshow/dendrimers-for-target-drug-delivery-in-treatment-of-cancer/144934614 SawsanMonir@slideshare.net(SawsanMonir) Dendrimers for Target Drug Delivery In Treatment of Cancer SawsanMonir Dendrimers are emerging as potential non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. These polymers are highly branched, three-dimensional macromolecules with modifiable surface functionalities and available internal cavities that make them attractive as delivery systems for drug and gene delivery applications. Recent work has suggested that dendrimers may be a keystone in the future of therapeutics, Dendrimers can also be being applied to a variety of cancer therapies to improve their safety and efficacy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reviewarticle-190511064848-thumbnail.jpg?width=120&height=120&fit=bounds" /> Dendrimers are emerging as potential non-viral vectors for efficiently delivering drugs and nucleic acids to the cancer cells. These polymers are highly branched, three-dimensional macromolecules with modifiable surface functionalities and available internal cavities that make them attractive as delivery systems for drug and gene delivery applications. Recent work has suggested that dendrimers may be a keystone in the future of therapeutics, Dendrimers can also be being applied to a variety of cancer therapies to improve their safety and efficacy.

Dendrimers for Target Drug Delivery In Treatment of Cancer from Sawsan Monir

]]> 308 7 https://cdn.slidesharecdn.com/ss_thumbnails/reviewarticle-190511064848-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 treatment of Mushroom toxicity /slideshow/treatment-of-mushroom-toxicity/144933466 mushroomtreatment-190511063854
Gut decontamination, including whole-bowel irrigation, may be necessary for amatoxins. Beyond the first postprandial hour, orogastric lavage is not recommended, because of its questionable efficacy. Activated charcoal plays a much more important role in limiting absorption of most toxins and is indicated for all patients with amatoxin mushroom poisoning, regardless of the timing of presentation. Muscarine poisoning Most patients with poisoning due to mushrooms containing muscarine can be treated without medications. If patients exhibit excessive bronchial secretions or other symptoms of cholinergic excess (bradycardia) that are of significant concern, atropine (small doses) infusion may decrease these symptoms. Liver transplantation Indications for immediate OLT include the following: Stage III hepatic encephalopathy Serum bilirubin levels higher than 4.6 mg/dL Prothrombin time (PT) prolongation unresponsive to FFP infusions (patients with a PT >100 s should be considered for transplantation) Age younger than 12 years Serum creatinine level higher than 1.4 mg/dL Hemorrhage Shock Acidosis Hypoglycemia Oral form silymarin may be obtained. Other recommended therapies for amatoxin poisoning include the following: IV benzyl penicillin – Reduces the uptake of amatoxin by hepatocytes Cimetidine - Inhibits CYP450 enzymes, presumably reducing metabolism of alpha-amanitin into hepatotoxic metabolites N -acetylcysteine (NAC) - A thiol containing glutathione precursor with free radical binding capacity and antioxidant effects Systemic toxicity and seizures results from reduced concentrations of GABA overcome by the infusions of pyridoxine (vitamin B-6) if they do not respond to benzodiazepines. Inhibit the transformation of folic acid to tetrahydrofolic acid. Therefore, patients with severe gyromitrin toxicity should receive folinic acid, as an adjunctive therapy management of complications of poisoning Rhabdomyolysis is treated with aggressive IV fluid resuscitation Methemoglobinemia is treated with IV methylene blue Hemolysis is usually mild, necessitates the administration of large amounts of IV fluids only to prevent renal complications; blood transfusions are rarely required. ]]>
Gut decontamination, including whole-bowel irrigation, may be necessary for amatoxins. Beyond the first postprandial hour, orogastric lavage is not recommended, because of its questionable efficacy. Activated charcoal plays a much more important role in limiting absorption of most toxins and is indicated for all patients with amatoxin mushroom poisoning, regardless of the timing of presentation. Muscarine poisoning Most patients with poisoning due to mushrooms containing muscarine can be treated without medications. If patients exhibit excessive bronchial secretions or other symptoms of cholinergic excess (bradycardia) that are of significant concern, atropine (small doses) infusion may decrease these symptoms. Liver transplantation Indications for immediate OLT include the following: Stage III hepatic encephalopathy Serum bilirubin levels higher than 4.6 mg/dL Prothrombin time (PT) prolongation unresponsive to FFP infusions (patients with a PT >100 s should be considered for transplantation) Age younger than 12 years Serum creatinine level higher than 1.4 mg/dL Hemorrhage Shock Acidosis Hypoglycemia Oral form silymarin may be obtained. Other recommended therapies for amatoxin poisoning include the following: IV benzyl penicillin – Reduces the uptake of amatoxin by hepatocytes Cimetidine - Inhibits CYP450 enzymes, presumably reducing metabolism of alpha-amanitin into hepatotoxic metabolites N -acetylcysteine (NAC) - A thiol containing glutathione precursor with free radical binding capacity and antioxidant effects Systemic toxicity and seizures results from reduced concentrations of GABA overcome by the infusions of pyridoxine (vitamin B-6) if they do not respond to benzodiazepines. Inhibit the transformation of folic acid to tetrahydrofolic acid. Therefore, patients with severe gyromitrin toxicity should receive folinic acid, as an adjunctive therapy management of complications of poisoning Rhabdomyolysis is treated with aggressive IV fluid resuscitation Methemoglobinemia is treated with IV methylene blue Hemolysis is usually mild, necessitates the administration of large amounts of IV fluids only to prevent renal complications; blood transfusions are rarely required. ]]> Sat, 11 May 2019 06:38:54 GMT /slideshow/treatment-of-mushroom-toxicity/144933466 SawsanMonir@slideshare.net(SawsanMonir) treatment of Mushroom toxicity SawsanMonir Gut decontamination, including whole-bowel irrigation, may be necessary for amatoxins. Beyond the first postprandial hour, orogastric lavage is not recommended, because of its questionable efficacy. Activated charcoal plays a much more important role in limiting absorption of most toxins and is indicated for all patients with amatoxin mushroom poisoning, regardless of the timing of presentation. Muscarine poisoning Most patients with poisoning due to mushrooms containing muscarine can be treated without medications. If patients exhibit excessive bronchial secretions or other symptoms of cholinergic excess (bradycardia) that are of significant concern, atropine (small doses) infusion may decrease these symptoms. Liver transplantation Indications for immediate OLT include the following: Stage III hepatic encephalopathy Serum bilirubin levels higher than 4.6 mg/dL Prothrombin time (PT) prolongation unresponsive to FFP infusions (patients with a PT >100 s should be considered for transplantation) Age younger than 12 years Serum creatinine level higher than 1.4 mg/dL Hemorrhage Shock Acidosis Hypoglycemia Oral form silymarin may be obtained. Other recommended therapies for amatoxin poisoning include the following: IV benzyl penicillin – Reduces the uptake of amatoxin by hepatocytes Cimetidine - Inhibits CYP450 enzymes, presumably reducing metabolism of alpha-amanitin into hepatotoxic metabolites N -acetylcysteine (NAC) - A thiol containing glutathione precursor with free radical binding capacity and antioxidant effects Systemic toxicity and seizures results from reduced concentrations of GABA overcome by the infusions of pyridoxine (vitamin B-6) if they do not respond to benzodiazepines. Inhibit the transformation of folic acid to tetrahydrofolic acid. Therefore, patients with severe gyromitrin toxicity should receive folinic acid, as an adjunctive therapy management of complications of poisoning Rhabdomyolysis is treated with aggressive IV fluid resuscitation Methemoglobinemia is treated with IV methylene blue Hemolysis is usually mild, necessitates the administration of large amounts of IV fluids only to prevent renal complications; blood transfusions are rarely required. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/mushroomtreatment-190511063854-thumbnail.jpg?width=120&height=120&fit=bounds" /> Gut decontamination, including whole-bowel irrigation, may be necessary for amatoxins. Beyond the first postprandial hour, orogastric lavage is not recommended, because of its questionable efficacy. Activated charcoal plays a much more important role in limiting absorption of most toxins and is indicated for all patients with amatoxin mushroom poisoning, regardless of the timing of presentation. Muscarine poisoning Most patients with poisoning due to mushrooms containing muscarine can be treated without medications. If patients exhibit excessive bronchial secretions or other symptoms of cholinergic excess (bradycardia) that are of significant concern, atropine (small doses) infusion may decrease these symptoms. Liver transplantation Indications for immediate OLT include the following: Stage III hepatic encephalopathy Serum bilirubin levels higher than 4.6 mg/dL Prothrombin time (PT) prolongation unresponsive to FFP infusions (patients with a PT >100 s should be considered for transplantation) Age younger than 12 years Serum creatinine level higher than 1.4 mg/dL Hemorrhage Shock Acidosis Hypoglycemia Oral form silymarin may be obtained. Other recommended therapies for amatoxin poisoning include the following: IV benzyl penicillin – Reduces the uptake of amatoxin by hepatocytes Cimetidine - Inhibits CYP450 enzymes, presumably reducing metabolism of alpha-amanitin into hepatotoxic metabolites N -acetylcysteine (NAC) - A thiol containing glutathione precursor with free radical binding capacity and antioxidant effects Systemic toxicity and seizures results from reduced concentrations of GABA overcome by the infusions of pyridoxine (vitamin B-6) if they do not respond to benzodiazepines. Inhibit the transformation of folic acid to tetrahydrofolic acid. Therefore, patients with severe gyromitrin toxicity should receive folinic acid, as an adjunctive therapy management of complications of poisoning Rhabdomyolysis is treated with aggressive IV fluid resuscitation Methemoglobinemia is treated with IV methylene blue Hemolysis is usually mild, necessitates the administration of large amounts of IV fluids only to prevent renal complications; blood transfusions are rarely required.

treatment of Mushroom toxicity from Sawsan Monir

]]> 753 2 https://cdn.slidesharecdn.com/ss_thumbnails/mushroomtreatment-190511063854-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Scorpion venom /slideshow/scorpion-venom/144932904 scorpionvenom-190511063452
An insect that has an elongated body and a segmented, curved tail tipped with a venomous stinger. A sting can be fatal to a person who is allergic to it. The toxicity of scorpion venom varies by species. A given species' venom may contain many chemicals, some toxic to insects, others toxic to mammals. Scorpion species with smaller and more slender claws generally have more toxic venom. Scorpion stings are much more dangerous for infants and small children. ]]>
An insect that has an elongated body and a segmented, curved tail tipped with a venomous stinger. A sting can be fatal to a person who is allergic to it. The toxicity of scorpion venom varies by species. A given species' venom may contain many chemicals, some toxic to insects, others toxic to mammals. Scorpion species with smaller and more slender claws generally have more toxic venom. Scorpion stings are much more dangerous for infants and small children. ]]> Sat, 11 May 2019 06:34:52 GMT /slideshow/scorpion-venom/144932904 SawsanMonir@slideshare.net(SawsanMonir) Scorpion venom SawsanMonir An insect that has an elongated body and a segmented, curved tail tipped with a venomous stinger. A sting can be fatal to a person who is allergic to it. The toxicity of scorpion venom varies by species. A given species' venom may contain many chemicals, some toxic to insects, others toxic to mammals. Scorpion species with smaller and more slender claws generally have more toxic venom. Scorpion stings are much more dangerous for infants and small children. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/scorpionvenom-190511063452-thumbnail.jpg?width=120&height=120&fit=bounds" /> An insect that has an elongated body and a segmented, curved tail tipped with a venomous stinger. A sting can be fatal to a person who is allergic to it. The toxicity of scorpion venom varies by species. A given species' venom may contain many chemicals, some toxic to insects, others toxic to mammals. Scorpion species with smaller and more slender claws generally have more toxic venom. Scorpion stings are much more dangerous for infants and small children.

Scorpion venom from Sawsan Monir

]]> 1409 1 https://cdn.slidesharecdn.com/ss_thumbnails/scorpionvenom-190511063452-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Nano spray drying technology for heat sensitive biopharmaceuticals /slideshow/nano-spray-drying-technology-for-heat-sensitive-biopharmaceuticals/144928192 nanospraydryingtechnologyforheatsensitivebiopharmaceuticals-190511060014
Numerous drying methods have been used for preparing dried protein powders, although that choosing a suitable drying technique remains a challenge. In this thesis, we will discuss spray drying as a drying method for improving the stability and bioavailability of therapeutic proteins. Spray drying is a simple, fast, continuous, and scalable drying technology that is well established in biotechnological and pharmaceutical industry as for excipient production, micro-encapsulation, or granulation also it plays a crucial role in the processing of pharmaceutical products such as pills, capsules, and tablets as it is used to convert drug-containing liquids into dried powdered forms. Nano spray drying is in particular used to improve drug formulation by encapsulating active ingredients in polymeric wall materials for protection and delivering the drugs to the right place and time in the body. The Nano spray dryer developed in the recent years extends the spectrum of produced powder particles to the submicron- and Nano scale with very narrow size distributions and sample quantities in the milligram scale at high product yields. This enables the economical use of expensive active pharmaceutical ingredients and pure drugs. Critical process parameters like atomization pressure and cap size, feed rate, feed pressure, inlet and outlet temperature, residence time inside drying chamber and drying gas flow rate are optimized based on the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications as they produce particles with different sizes and morphologies.]]>
Numerous drying methods have been used for preparing dried protein powders, although that choosing a suitable drying technique remains a challenge. In this thesis, we will discuss spray drying as a drying method for improving the stability and bioavailability of therapeutic proteins. Spray drying is a simple, fast, continuous, and scalable drying technology that is well established in biotechnological and pharmaceutical industry as for excipient production, micro-encapsulation, or granulation also it plays a crucial role in the processing of pharmaceutical products such as pills, capsules, and tablets as it is used to convert drug-containing liquids into dried powdered forms. Nano spray drying is in particular used to improve drug formulation by encapsulating active ingredients in polymeric wall materials for protection and delivering the drugs to the right place and time in the body. The Nano spray dryer developed in the recent years extends the spectrum of produced powder particles to the submicron- and Nano scale with very narrow size distributions and sample quantities in the milligram scale at high product yields. This enables the economical use of expensive active pharmaceutical ingredients and pure drugs. Critical process parameters like atomization pressure and cap size, feed rate, feed pressure, inlet and outlet temperature, residence time inside drying chamber and drying gas flow rate are optimized based on the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications as they produce particles with different sizes and morphologies.]]> Sat, 11 May 2019 06:00:14 GMT /slideshow/nano-spray-drying-technology-for-heat-sensitive-biopharmaceuticals/144928192 SawsanMonir@slideshare.net(SawsanMonir) Nano spray drying technology for heat sensitive biopharmaceuticals SawsanMonir Numerous drying methods have been used for preparing dried protein powders, although that choosing a suitable drying technique remains a challenge. In this thesis, we will discuss spray drying as a drying method for improving the stability and bioavailability of therapeutic proteins. Spray drying is a simple, fast, continuous, and scalable drying technology that is well established in biotechnological and pharmaceutical industry as for excipient production, micro-encapsulation, or granulation also it plays a crucial role in the processing of pharmaceutical products such as pills, capsules, and tablets as it is used to convert drug-containing liquids into dried powdered forms. Nano spray drying is in particular used to improve drug formulation by encapsulating active ingredients in polymeric wall materials for protection and delivering the drugs to the right place and time in the body. The Nano spray dryer developed in the recent years extends the spectrum of produced powder particles to the submicron- and Nano scale with very narrow size distributions and sample quantities in the milligram scale at high product yields. This enables the economical use of expensive active pharmaceutical ingredients and pure drugs. Critical process parameters like atomization pressure and cap size, feed rate, feed pressure, inlet and outlet temperature, residence time inside drying chamber and drying gas flow rate are optimized based on the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications as they produce particles with different sizes and morphologies. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nanospraydryingtechnologyforheatsensitivebiopharmaceuticals-190511060014-thumbnail.jpg?width=120&height=120&fit=bounds" /> Numerous drying methods have been used for preparing dried protein powders, although that choosing a suitable drying technique remains a challenge. In this thesis, we will discuss spray drying as a drying method for improving the stability and bioavailability of therapeutic proteins. Spray drying is a simple, fast, continuous, and scalable drying technology that is well established in biotechnological and pharmaceutical industry as for excipient production, micro-encapsulation, or granulation also it plays a crucial role in the processing of pharmaceutical products such as pills, capsules, and tablets as it is used to convert drug-containing liquids into dried powdered forms. Nano spray drying is in particular used to improve drug formulation by encapsulating active ingredients in polymeric wall materials for protection and delivering the drugs to the right place and time in the body. The Nano spray dryer developed in the recent years extends the spectrum of produced powder particles to the submicron- and Nano scale with very narrow size distributions and sample quantities in the milligram scale at high product yields. This enables the economical use of expensive active pharmaceutical ingredients and pure drugs. Critical process parameters like atomization pressure and cap size, feed rate, feed pressure, inlet and outlet temperature, residence time inside drying chamber and drying gas flow rate are optimized based on the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications as they produce particles with different sizes and morphologies.

Nano spray drying technology for heat sensitive biopharmaceuticals from Sawsan Monir

]]> 325 8 https://cdn.slidesharecdn.com/ss_thumbnails/nanospraydryingtechnologyforheatsensitivebiopharmaceuticals-190511060014-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Decision analysis & Markov chain /slideshow/decision-analysis-markov-chain/86389757 economics-180119062254
Decision analysis DEFINITION of 'Decision Analysis - DA' A systematic, quantitative and visual approach to addressing and evaluating important choices confronted by businesses. Decision analysis utilizes a variety of tools to evaluate all relevant information to aid in the decision making process. A graphical representation of alternatives and possible solutions, as well as challenges and uncertainties, can be created on a decision tree or influence diagram. Decision analysis (DA) has been applied to business problems in management, marketing, operations, accounting, and finance. In addition, it has had an impact on the fields of medicine, law, military science, environmental sciences, and public policy more generally. Markov chain: Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues.]]>
Decision analysis DEFINITION of 'Decision Analysis - DA' A systematic, quantitative and visual approach to addressing and evaluating important choices confronted by businesses. Decision analysis utilizes a variety of tools to evaluate all relevant information to aid in the decision making process. A graphical representation of alternatives and possible solutions, as well as challenges and uncertainties, can be created on a decision tree or influence diagram. Decision analysis (DA) has been applied to business problems in management, marketing, operations, accounting, and finance. In addition, it has had an impact on the fields of medicine, law, military science, environmental sciences, and public policy more generally. Markov chain: Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues.]]> Fri, 19 Jan 2018 06:22:54 GMT /slideshow/decision-analysis-markov-chain/86389757 SawsanMonir@slideshare.net(SawsanMonir) Decision analysis & Markov chain SawsanMonir Decision analysis DEFINITION of 'Decision Analysis - DA' A systematic, quantitative and visual approach to addressing and evaluating important choices confronted by businesses. Decision analysis utilizes a variety of tools to evaluate all relevant information to aid in the decision making process. A graphical representation of alternatives and possible solutions, as well as challenges and uncertainties, can be created on a decision tree or influence diagram. Decision analysis (DA) has been applied to business problems in management, marketing, operations, accounting, and finance. In addition, it has had an impact on the fields of medicine, law, military science, environmental sciences, and public policy more generally. Markov chain: Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/economics-180119062254-thumbnail.jpg?width=120&height=120&fit=bounds" /> Decision analysis DEFINITION of 'Decision Analysis - DA' A systematic, quantitative and visual approach to addressing and evaluating important choices confronted by businesses. Decision analysis utilizes a variety of tools to evaluate all relevant information to aid in the decision making process. A graphical representation of alternatives and possible solutions, as well as challenges and uncertainties, can be created on a decision tree or influence diagram. Decision analysis (DA) has been applied to business problems in management, marketing, operations, accounting, and finance. In addition, it has had an impact on the fields of medicine, law, military science, environmental sciences, and public policy more generally. Markov chain: Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues.

Decision analysis & Markov chain from Sawsan Monir

]]> 1369 4 https://cdn.slidesharecdn.com/ss_thumbnails/economics-180119062254-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Marketing /slideshow/marketing-86389293/86389293 marketing-180119060946
Market segmentation: It is the process of dividing a broad consumer or business market, normally consisting of existing and potential customers, into sub-groups of consumers (known as segments) based on some type of shared characteristics such as shared needs, common interests, similar lifestyles or even similar demographic profiles. Pricing strategies: Good pricing strategy helps you determine the price point at which you can maximize profits on sales of your products or services. When setting prices, a business owner needs to consider a wide range of factors including production and distribution costs, competitor offerings, positioning strategies and the business’ target customer base. Consumer Adoption Process: The Consumer Adoption Process is a 5 step mental process by which all the customers/ consumer go through while adopting a product from learning about a new product to becoming a happy loyal user of that product or to decline/reject the product completely. The process of a consumer of moving from a cognitive state toward the emotional state and finally reaching towards the behavioral or conative state is another way to explain Consumer Adoption Process. Buyer decision making process: The customer buying process (also called a buying decision process) describes the journey your customer goes through before they buy your product. ]]>
Market segmentation: It is the process of dividing a broad consumer or business market, normally consisting of existing and potential customers, into sub-groups of consumers (known as segments) based on some type of shared characteristics such as shared needs, common interests, similar lifestyles or even similar demographic profiles. Pricing strategies: Good pricing strategy helps you determine the price point at which you can maximize profits on sales of your products or services. When setting prices, a business owner needs to consider a wide range of factors including production and distribution costs, competitor offerings, positioning strategies and the business’ target customer base. Consumer Adoption Process: The Consumer Adoption Process is a 5 step mental process by which all the customers/ consumer go through while adopting a product from learning about a new product to becoming a happy loyal user of that product or to decline/reject the product completely. The process of a consumer of moving from a cognitive state toward the emotional state and finally reaching towards the behavioral or conative state is another way to explain Consumer Adoption Process. Buyer decision making process: The customer buying process (also called a buying decision process) describes the journey your customer goes through before they buy your product. ]]> Fri, 19 Jan 2018 06:09:46 GMT /slideshow/marketing-86389293/86389293 SawsanMonir@slideshare.net(SawsanMonir) Marketing SawsanMonir Market segmentation: It is the process of dividing a broad consumer or business market, normally consisting of existing and potential customers, into sub-groups of consumers (known as segments) based on some type of shared characteristics such as shared needs, common interests, similar lifestyles or even similar demographic profiles. Pricing strategies: Good pricing strategy helps you determine the price point at which you can maximize profits on sales of your products or services. When setting prices, a business owner needs to consider a wide range of factors including production and distribution costs, competitor offerings, positioning strategies and the business’ target customer base. Consumer Adoption Process: The Consumer Adoption Process is a 5 step mental process by which all the customers/ consumer go through while adopting a product from learning about a new product to becoming a happy loyal user of that product or to decline/reject the product completely. The process of a consumer of moving from a cognitive state toward the emotional state and finally reaching towards the behavioral or conative state is another way to explain Consumer Adoption Process. Buyer decision making process: The customer buying process (also called a buying decision process) describes the journey your customer goes through before they buy your product. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/marketing-180119060946-thumbnail.jpg?width=120&height=120&fit=bounds" /> Market segmentation: It is the process of dividing a broad consumer or business market, normally consisting of existing and potential customers, into sub-groups of consumers (known as segments) based on some type of shared characteristics such as shared needs, common interests, similar lifestyles or even similar demographic profiles. Pricing strategies: Good pricing strategy helps you determine the price point at which you can maximize profits on sales of your products or services. When setting prices, a business owner needs to consider a wide range of factors including production and distribution costs, competitor offerings, positioning strategies and the business’ target customer base. Consumer Adoption Process: The Consumer Adoption Process is a 5 step mental process by which all the customers/ consumer go through while adopting a product from learning about a new product to becoming a happy loyal user of that product or to decline/reject the product completely. The process of a consumer of moving from a cognitive state toward the emotional state and finally reaching towards the behavioral or conative state is another way to explain Consumer Adoption Process. Buyer decision making process: The customer buying process (also called a buying decision process) describes the journey your customer goes through before they buy your product.

Marketing from Sawsan Monir

]]> 206 3 https://cdn.slidesharecdn.com/ss_thumbnails/marketing-180119060946-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Monosomy 7 /slideshow/monosomy-7-86388708/86388708 monosomy-7-180119055222
Monosomy 7 Monosomy 7 or partial deletion of the long arm of chromosome 7 (7q-) is a frequent cytogenetic finding in the bone marrow of patients with myelodysplasia (MDS) and acute myelogenous leukemia (AML). Furthermore, monosomy 7 or 7q- is the most frequent abnormality of karyotype in cases of AML that occur after cytotoxic cancer therapy or occupational exposure to mutagens. The age distribution of de novo cases shows peaks in the first and fifth decades. Monosomy 7 is found in about 5% of de novo and 40% of secondary cases of AML. These findings suggest that loss of certain genes at this region is an important event in the development of myelodysplasia ]]>
Monosomy 7 Monosomy 7 or partial deletion of the long arm of chromosome 7 (7q-) is a frequent cytogenetic finding in the bone marrow of patients with myelodysplasia (MDS) and acute myelogenous leukemia (AML). Furthermore, monosomy 7 or 7q- is the most frequent abnormality of karyotype in cases of AML that occur after cytotoxic cancer therapy or occupational exposure to mutagens. The age distribution of de novo cases shows peaks in the first and fifth decades. Monosomy 7 is found in about 5% of de novo and 40% of secondary cases of AML. These findings suggest that loss of certain genes at this region is an important event in the development of myelodysplasia ]]> Fri, 19 Jan 2018 05:52:21 GMT /slideshow/monosomy-7-86388708/86388708 SawsanMonir@slideshare.net(SawsanMonir) Monosomy 7 SawsanMonir Monosomy 7 Monosomy 7 or partial deletion of the long arm of chromosome 7 (7q-) is a frequent cytogenetic finding in the bone marrow of patients with myelodysplasia (MDS) and acute myelogenous leukemia (AML). Furthermore, monosomy 7 or 7q- is the most frequent abnormality of karyotype in cases of AML that occur after cytotoxic cancer therapy or occupational exposure to mutagens. The age distribution of de novo cases shows peaks in the first and fifth decades. Monosomy 7 is found in about 5% of de novo and 40% of secondary cases of AML. These findings suggest that loss of certain genes at this region is an important event in the development of myelodysplasia <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/monosomy-7-180119055222-thumbnail.jpg?width=120&height=120&fit=bounds" /> Monosomy 7 Monosomy 7 or partial deletion of the long arm of chromosome 7 (7q-) is a frequent cytogenetic finding in the bone marrow of patients with myelodysplasia (MDS) and acute myelogenous leukemia (AML). Furthermore, monosomy 7 or 7q- is the most frequent abnormality of karyotype in cases of AML that occur after cytotoxic cancer therapy or occupational exposure to mutagens. The age distribution of de novo cases shows peaks in the first and fifth decades. Monosomy 7 is found in about 5% of de novo and 40% of secondary cases of AML. These findings suggest that loss of certain genes at this region is an important event in the development of myelodysplasia

Monosomy 7 from Sawsan Monir

]]> 994 3 https://cdn.slidesharecdn.com/ss_thumbnails/monosomy-7-180119055222-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/reviewarticle-190511064848-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/dendrimers-for-target-drug-delivery-in-treatment-of-cancer/144934614 Dendrimers for Target ... https://cdn.slidesharecdn.com/ss_thumbnails/mushroomtreatment-190511063854-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/treatment-of-mushroom-toxicity/144933466 treatment of Mushroom ... https://cdn.slidesharecdn.com/ss_thumbnails/scorpionvenom-190511063452-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/scorpion-venom/144932904 Scorpion venom